Arcus Biosciences Insider Trades

RCUS

Track insider trading activity from Arcus Biosciences executives and directors. See which insiders are buying and selling RCUS stock.

Trades Last 12 Months

RCUS Price

All Insider Trades for Arcus Biosciences

Sort by: Latest Trade Biggest Holding
Insider
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Azoy Alexander Chief Accounting Officer
Holding Value $79.4k 3,073 shares
Last Trade
Aug 21, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$83.4k 2,827 shares
$29.51
$25.83
Jaen Juan C. President
Holding Value $21.2M 822,508 shares
Last Trade
Jul 10, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$574k 20,067 shares
$28.62
$25.83
Tang Carolyn C. General Counsel
Holding Value $4.77M 184,607 shares
Last Trade
Jun 11, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$794k 34,090 shares
$23.30
$25.83
Holding Value $1.14M 44,300 shares
Last Trade
Jun 11, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$527k 22,600 shares
$23.30
$25.83
Kaneko Yasunori Director
Holding Value $664k 25,700 shares
Last Trade
Jun 11, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$527k 22,600 shares
$23.30
$25.83
Lacey David L. Director
Holding Value $1.98M 76,652 shares
Last Trade
Jun 11, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$527k 22,600 shares
$23.30
$25.83
Lambert Nicole Director
Holding Value $1.11M 43,000 shares
Last Trade
Jun 11, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$527k 22,600 shares
$23.30
$25.83
Machado Patrick Director
Holding Value $1.14M 44,300 shares
Last Trade
Jun 11, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$527k 22,600 shares
$23.30
$25.83
Perlman Andrew J Director
Holding Value $1.25M 48,325 shares
Last Trade
Jun 11, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$527k 22,600 shares
$23.30
$25.83
Ribas Antoni Director
Holding Value $1.14M 44,300 shares
Last Trade
Jun 11, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$527k 22,600 shares
$23.30
$25.83
Goeltz Ii Robert C. Chief Financial Officer
Holding Value $2.17M 84,161 shares
Last Trade
May 11, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$199k 7,763 shares
$25.63
$25.83
Jarrett Jennifer Chief Operating Officer
Holding Value $5.79M 224,024 shares
Last Trade
Jan 23, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.47M 157,000 shares
$22.13
$25.83
Markus Richard Chief Medical Officer
Holding Value $2.48M 96,000 shares
Last Trade
Jan 23, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.66M 120,000 shares
$22.13
$25.83
Rosen Terry J Chief Executive Officer
Holding Value $8.14M 315,000 shares
Last Trade
Jan 23, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$6.97M 315,000 shares
$22.13
$25.83
Perlman Andrew J Director
Holding Value $1.1M 42,625 shares
Last Trade
Jun 10, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$384k 38,300 shares
$10.02
$25.83
Kaneko Yasunori Director
Holding Value $989k 38,300 shares
Last Trade
Jun 10, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$384k 38,300 shares
$10.02
$25.83
Holding Value $1.77M 68,600 shares
Last Trade
Jun 10, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$384k 38,300 shares
$10.02
$25.83
Holding Value $812M 31,424,760 shares
Last Trade
Feb 18, 2025 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$15M 1,363,636 shares
$11.00
$25.83
Nuyten Dimitry Sa Chief Medical Officer
Holding Value $2.26M 87,518 shares
Last Trade
Dec 15, 2024 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$126k 7,856 shares
$16.08
$25.83
Grossman William Chief Medical Officer
Holding Value $535k 20,723 shares
Last Trade
Jun 17, 2021 Sale (Open Market)Shares sold on the open market or in a private sale.
$92.1k 3,891 shares
$23.68
$25.83

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up